MYH9 and glomerulosclerosis: According to genome-wide association studies (GWAS), polymorphisms in MYH9 have been reported to be strongly associated with ESRD, including focal segmental glomerulosclerosis (FSGS), global glomerulosclerosis, diabetic nephropathy, and collapsing glomerulopathy [35–37].